Hannah Tharmalingam

Dr. Hannah Tharmalingam


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2019 in Nature Reviews Urology
Verified
Journal Article
Closed access
PDF file
HTHannah Tharmalingam
Hannah Tharmalingam
ACAnanya Choudhury
Ananya Choudhury
MHMarcel Van Herk
Marcel Van Herk
AMAlan McWilliam
Alan McWilliam
PHPeter J. Hoskin
Peter J. Hoskin

1 February 2020 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
HTHannah Tharmalingam
Hannah Tharmalingam
YTYatman Tsang
Yatman Tsang
POPeter Ostler
Peter Ostler
JWJames Wylie
James Wylie
ABAmit Bahl
Amit Bahl
PHPeter J. Hoskin
Peter J. Hoskin

2 December 2019 in British Journal of Radiology
Verified
Journal Article
Closed access
YTYat Man Tsang
Yat Man Tsang
DVDinesh Vignarajah
Dinesh Vignarajah
AMAlan Mcwilliam
Alan Mcwilliam
HTHannah Tharmalingam
Hannah Tharmalingam
GLGerry Lowe
Gerry Lowe
PHPeter Hoskin
Peter Hoskin
Objective: A cohort of high dose-rate (HDR) monotherapy patients was analyzed to (i) establish the frequency of non-malignant urethral stricture; (ii) explore the relation between stricture formation with the dose distribution along the length of the urethra, and MRI radiomics features of the prostate gland. Methods: A retrospective review of treatment records of patients who received 19 Gy single fraction of HDR brachytherapy (BT) was carried out. A matched pair analysis used one control for each stricture case matched with pre-treatment International Prostate Symptom Score (IPSS) score, number of needles used and clinical target volume volume for each stricture case identified. For all data sets, pre-treatment T 2 weighted MRI images were used to define regions of interests along the urethra and within the whole prostate gland. MRI textural radiomics features—energy, contrast and homogeneity were selected. Wilcoxon signed-rank test was performed to investigate significant differences in dosimetric parameters and MRI radiomics feature values between cases and controls. Results: From Nov 2010 to July 2017, there were 178 patients treated with HDR BT delivering 19 Gy in a single dose. With a median follow-up of 28.2 months, a total of 5/178 (3%) strictures were identified. 10 patients were included in the matched pair analysis. The urethral dosimetric parameters investigated were not statistically different between cases and controls (p > 0.05). With regards to MRI radiomics feature analysis, significant differences were found in contrast and homogeneity between cases and controls (p < 0.05). However, this did not apply to the energy feature (p = 0.28). Conclusion: In this matched pair analysis, no association between post-treatment stricture and urethral dosimetry was identified. Our study generated a preliminary clinical hypothesis suggesting that the MRI radiomics features of homogeneity and contrast of the prostate gland can potentially identify patients who develop strictures after HDR BT. Although the sample size is small, this warrants further validation in a larger patient cohort. Advances in knowledge: Urethral stricture has been reported as a specific late effect with prostate HDR brachytherapy. Our study reported a relatively low stricture rate of 3% and no association between post-treatment stricture and urethral dosimetry was identified. MRI radiomics features can potentially identify patients who are more prone to develop strictures.

1 November 2018 in Clinical Oncology
Verified
Journal Article
Closed access
HTHannah Tharmalingam
Hannah Tharmalingam
RAR. Alonzi
R. Alonzi
PHP.J. Hoskin
P.J. Hoskin

1 October 2018 in Clinical Oncology
Verified
Journal Article
Closed access
HTHannah Tharmalingam
Hannah Tharmalingam
AVA. Vinayan
A. Vinayan
NAN. Anyamene
N. Anyamene

11 June 2020 in Clinical Oncology
Verified
Journal Article
Closed access
PDF file
HTHannah Tharmalingam
Hannah Tharmalingam
PDP. Díez
P. Díez
YTY. Tsang
Y. Tsang
AHA. Hawksley
A. Hawksley
JCJ. Conibear
J. Conibear
NTN. Thiruthaneeswaran
N. Thiruthaneeswaran